These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11900945)

  • 41. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
    Duane TM; Capitano B; Puzniak LA; Biswas P; Joshi M
    Surg Infect (Larchmt); 2013 Aug; 14(4):401-7. PubMed ID: 23859675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linezolid: an oxazolidinone antimicrobial agent.
    Paladino JA
    Am J Health Syst Pharm; 2002 Dec; 59(24):2413-25. PubMed ID: 12503340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linezolid.
    French G
    Int J Clin Pract; 2001; 55(1):59-63. PubMed ID: 11219321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections.
    Johnson JR
    Clin Infect Dis; 2003 Jan; 36(2):236-7. PubMed ID: 12522761
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
    Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
    Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibility.
    Scheetz MH; Knechtel SA; Postelnick MJ; Malczynski M; Qi C
    Pharmacotherapy; 2010 Dec; 30(12):1221-8. PubMed ID: 21114389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
    Bogomolova NS; Bol'shakov LV; Kuznetsova SM; Oreshkina TD
    Antibiot Khimioter; 2011; 56(5-6):37-45. PubMed ID: 22145229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V; Garcia-Diaz J; Islam T; Hasbun R
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
    Melzer M; Goldsmith D; Gransden W
    Clin Infect Dis; 2000 Jul; 31(1):208-9. PubMed ID: 10913433
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.
    Shukla BS; Gauthier TP; Correa R; Smith L; Abbo L
    Int J Clin Pharm; 2013 Oct; 35(5):697-703. PubMed ID: 23893061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
    Powers JH; Ross DB; Lin D; Soreth J
    Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
    [No Abstract]   [Full Text] [Related]  

  • 56. [Staphylococcus aureus and antibiotic resistance].
    Sancak B
    Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance].
    Klare I; Witte W; Wendt C; Werner G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1387-400. PubMed ID: 23114437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials.
    An MM; Shen H; Zhang JD; Xu GT; Jiang YY
    Int J Antimicrob Agents; 2013 May; 41(5):426-33. PubMed ID: 23537580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A review of linezolid: the first oxazolidinone antibiotic.
    Stevens DL; Dotter B; Madaras-Kelly K
    Expert Rev Anti Infect Ther; 2004 Feb; 2(1):51-9. PubMed ID: 15482171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Daniel Mullins C; Kuznik A; Shaya FT; Obeidat NA; Levine AR; Liu LZ; Wong W
    Clin Ther; 2006 Aug; 28(8):1184-1198. PubMed ID: 16982296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.